Additionally, Jhaveri et al. developed Tf-modified resveratrol liposomes (Tf-RES-L) for treating glioblastoma (GBM), which enhanced the anticancer effects of resveratrol, inhibited tumor growth, and extended mouse survival, demonstrating promising therapeutic potential [162]. The gene discussed is TF; the disease is glioblastoma.